Carefully selecting patients with MCI who might respond to the medicine Aduhelm is “becoming a priority,” one expert says.
New Alzheimer’s drug is for those with mild cognitive impairment. But who has that disorder?
Carefully selecting patients with MCI who might respond to the medicine Aduhelm is “becoming a priority,” one expert says.